vs
Side-by-side financial comparison of KeyCorp (KEY) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
KeyCorp is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.4× SELECT MEDICAL HOLDINGS CORP). KeyCorp runs the higher net margin — 25.4% vs 1.4%, a 24.0% gap on every dollar of revenue. On growth, KeyCorp posted the faster year-over-year revenue change (131.8% vs 6.4%). KeyCorp produced more free cash flow last quarter ($2.1B vs $5.2M). Over the past eight quarters, KeyCorp's revenue compounded faster (14.4% CAGR vs 2.8%).
Key is a Japanese visual novel studio known for making dramatic and plot-oriented titles. It was formed on July 21, 1998, as a brand under the publisher Visual Arts, and is located in Kita, Osaka.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
KEY vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.4B |
| Net Profit | $510.0M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | 32.3% | 4.6% |
| Net Margin | 25.4% | 1.4% |
| Revenue YoY | 131.8% | 6.4% |
| Net Profit YoY | 309.0% | 225.7% |
| EPS (diluted) | $0.43 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.0B | $1.4B | ||
| Q3 25 | $1.9B | $1.4B | ||
| Q2 25 | $1.8B | $1.3B | ||
| Q1 25 | $1.8B | $1.4B | ||
| Q4 24 | $865.0M | $1.3B | ||
| Q3 24 | $695.0M | $1.3B | ||
| Q2 24 | $1.5B | $1.3B | ||
| Q1 24 | $1.5B | $1.3B |
| Q4 25 | $510.0M | $20.2M | ||
| Q3 25 | $489.0M | $28.8M | ||
| Q2 25 | $425.0M | $40.6M | ||
| Q1 25 | $405.0M | $56.7M | ||
| Q4 24 | $-244.0M | $-16.1M | ||
| Q3 24 | $-410.0M | $55.6M | ||
| Q2 24 | $274.0M | $77.6M | ||
| Q1 24 | $219.0M | $96.9M |
| Q4 25 | 32.3% | 4.6% | ||
| Q3 25 | 31.8% | 5.4% | ||
| Q2 25 | 29.3% | 6.5% | ||
| Q1 25 | 29.0% | 8.3% | ||
| Q4 24 | -92.6% | 1.6% | ||
| Q3 24 | -72.8% | 4.3% | ||
| Q2 24 | 22.0% | 5.8% | ||
| Q1 24 | 18.1% | 9.0% |
| Q4 25 | 25.4% | 1.4% | ||
| Q3 25 | 25.8% | 2.1% | ||
| Q2 25 | 23.1% | 3.0% | ||
| Q1 25 | 22.8% | 4.2% | ||
| Q4 24 | -54.7% | -1.2% | ||
| Q3 24 | -59.0% | 4.4% | ||
| Q2 24 | 18.0% | 6.1% | ||
| Q1 24 | 14.3% | 7.3% |
| Q4 25 | $0.43 | $0.17 | ||
| Q3 25 | $0.41 | $0.23 | ||
| Q2 25 | $0.35 | $0.32 | ||
| Q1 25 | $0.33 | $0.44 | ||
| Q4 24 | $-0.30 | $-0.12 | ||
| Q3 24 | $-0.47 | $0.43 | ||
| Q2 24 | $0.25 | $0.60 | ||
| Q1 24 | $0.20 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.2B | $26.5M |
| Total DebtLower is stronger | $9.9B | $1.8B |
| Stockholders' EquityBook value | $20.4B | $1.7B |
| Total Assets | $184.4B | $5.9B |
| Debt / EquityLower = less leverage | 0.49× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.2B | $26.5M | ||
| Q3 25 | $13.3B | $60.1M | ||
| Q2 25 | $11.6B | $52.3M | ||
| Q1 25 | $15.3B | $53.2M | ||
| Q4 24 | $17.5B | $59.7M | ||
| Q3 24 | $22.8B | $191.5M | ||
| Q2 24 | $15.5B | $111.2M | ||
| Q1 24 | $13.2B | $92.6M |
| Q4 25 | $9.9B | $1.8B | ||
| Q3 25 | $10.9B | $1.7B | ||
| Q2 25 | $12.1B | $1.8B | ||
| Q1 25 | $12.4B | $1.8B | ||
| Q4 24 | $12.1B | $1.7B | ||
| Q3 24 | $15.7B | $3.1B | ||
| Q2 24 | $16.9B | $3.6B | ||
| Q1 24 | $20.8B | $3.8B |
| Q4 25 | $20.4B | $1.7B | ||
| Q3 25 | $20.1B | $1.7B | ||
| Q2 25 | $19.5B | $1.7B | ||
| Q1 25 | $19.0B | $1.7B | ||
| Q4 24 | $18.2B | $1.7B | ||
| Q3 24 | $16.9B | $1.9B | ||
| Q2 24 | $14.8B | $1.4B | ||
| Q1 24 | $14.5B | $1.4B |
| Q4 25 | $184.4B | $5.9B | ||
| Q3 25 | $187.4B | $5.7B | ||
| Q2 25 | $185.5B | $5.7B | ||
| Q1 25 | $188.7B | $5.7B | ||
| Q4 24 | $187.2B | $5.6B | ||
| Q3 24 | $189.8B | $8.0B | ||
| Q2 24 | $187.4B | $7.9B | ||
| Q1 24 | $187.5B | $7.9B |
| Q4 25 | 0.49× | 1.06× | ||
| Q3 25 | 0.54× | 1.03× | ||
| Q2 25 | 0.62× | 1.10× | ||
| Q1 25 | 0.65× | 1.03× | ||
| Q4 24 | 0.67× | 1.01× | ||
| Q3 24 | 0.93× | 1.62× | ||
| Q2 24 | 1.14× | 2.54× | ||
| Q1 24 | 1.43× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.2B | $64.3M |
| Free Cash FlowOCF − Capex | $2.1B | $5.2M |
| FCF MarginFCF / Revenue | 104.8% | 0.4% |
| Capex IntensityCapex / Revenue | 5.3% | 4.2% |
| Cash ConversionOCF / Net Profit | 4.33× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $3.5B | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2B | $64.3M | ||
| Q3 25 | $396.0M | $175.3M | ||
| Q2 25 | $1.2B | $110.3M | ||
| Q1 25 | $-140.0M | $-3.5M | ||
| Q4 24 | $664.0M | $125.4M | ||
| Q3 24 | $-1.2B | $181.0M | ||
| Q2 24 | $-217.0M | $278.2M | ||
| Q1 24 | $359.0M | $-66.7M |
| Q4 25 | $2.1B | $5.2M | ||
| Q3 25 | $367.0M | $122.2M | ||
| Q2 25 | $1.2B | $45.6M | ||
| Q1 25 | $-150.0M | $-55.8M | ||
| Q4 24 | $599.0M | $62.0M | ||
| Q3 24 | $-1.2B | $130.3M | ||
| Q2 24 | $-230.0M | $222.6M | ||
| Q1 24 | $347.0M | $-119.2M |
| Q4 25 | 104.8% | 0.4% | ||
| Q3 25 | 19.4% | 9.0% | ||
| Q2 25 | 65.8% | 3.4% | ||
| Q1 25 | -8.5% | -4.1% | ||
| Q4 24 | 69.2% | 4.7% | ||
| Q3 24 | -175.8% | 10.2% | ||
| Q2 24 | -15.1% | 17.4% | ||
| Q1 24 | 22.6% | -9.0% |
| Q4 25 | 5.3% | 4.2% | ||
| Q3 25 | 1.5% | 3.9% | ||
| Q2 25 | 1.3% | 4.8% | ||
| Q1 25 | 0.6% | 3.9% | ||
| Q4 24 | 7.5% | 4.8% | ||
| Q3 24 | 2.4% | 4.0% | ||
| Q2 24 | 0.9% | 4.3% | ||
| Q1 24 | 0.8% | 4.0% |
| Q4 25 | 4.33× | 3.19× | ||
| Q3 25 | 0.81× | 6.09× | ||
| Q2 25 | 2.90× | 2.72× | ||
| Q1 25 | -0.35× | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | -0.79× | 3.59× | ||
| Q1 24 | 1.64× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KEY
Segment breakdown not available.
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
